News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Paolini John F.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/27/2023 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 5,200 shares
@ $18.01, valued at
$93.7k
Sold 16,168 shares
@ $19.25, valued at
$311.2k
Sold 7,632 shares
@ $19.69, valued at
$150.3k
Exercised 29,000 options to buy
@ $1.86, valued at
$53.9k
|
|
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/03/2023 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 38,974 options to buy
@ $10.76, valued at
$419.4k
Granted 6,496 options to buy
@ $0 |
|
| 03/20/2023 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 507 shares
@ $11.46, valued at
$5.8k
Paid exercise price by delivering 1,078 shares
@ $11.12, valued at
$12k
Exercised 1,725 options to buy
@ $0
Exercised 3,671 options to buy
@ $0 |
|
| 11/09/2022 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 28,357 shares
@ $15.18, valued at
$430.5k
Exercised 28,357 options to buy
@ $1.86, valued at
$52.7k
|
|
| 09/06/2022 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Paid exercise price by delivering 507 shares
@ $11.44, valued at
$5.8k
Granted 59,930 options to buy
@ $11.97, valued at
$717.4k
Granted 9,990 options to buy
@ $0
Exercised 1,725 options to buy
@ $0 |
|
| 04/11/2022 |
4
| Paolini John F. (CHIEF MEDICAL OFFICER) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 59,930 options to buy
@ $11.1, valued at
$665.2k
Granted 9,990 options to buy
@ $0 |
|
| 03/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2020 |
4
| Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $15.5, valued at
$775k
|
|
| 03/17/2020 |
4
| Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 50,000 options to buy
@ $15.52, valued at
$776k
|
|
| 03/02/2020 |
4
| Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 12,000 options to buy
@ $1.86, valued at
$22.3k
|
|
| 02/21/2020 |
4
| Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 22,477 shares
@ $18.27, valued at
$410.7k
Sold 8,687 shares
@ $18.91, valued at
$164.3k
Sold 1,116 shares
@ $19.32, valued at
$21.6k
Exercised 22,477 options to buy
@ $3.8, valued at
$85.4k
Exercised 9,803 options to buy
@ $3.8, valued at
$37.3k
|
|
| 02/18/2020 |
4
| Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 10,277 shares
@ $18.29, valued at
$188k
Sold 1,039 shares
@ $18.33, valued at
$19k
Exercised 10,277 options to buy
@ $3.8, valued at
$39.1k
Exercised 1,039 options to buy
@ $3.8, valued at
$3.9k
|
|
| 12/09/2019 |
4
| Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 8,000 options to buy
@ $1.86, valued at
$14.9k
|
|
| 10/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2019 |
4
| Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 51,000 options to buy
@ $17.92, valued at
$913.9k
|
|
| 09/24/2018 |
4
| Paolini John F. (SVP & Chief Medical Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 45,000 options to buy
@ $30.93, valued at
$1.4M
|
|
| 05/23/2018 |
3
| Paolini John (Chief Medical Officer) has filed a Form 3 on Kiniksa Pharmaceuticals, Ltd. |
|
|